QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) An erratum has been published Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (37) Citing Articles via Google Scholar Google Scholar Articles by Ouimet, C. C. Articles by Greengard, P. Search for Related Content PubMed PubMed Citation Articles by Ouimet, C. C. Articles by Greengard, P.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 9, 865-875, Copyright © 1989 by Society for Neuroscience

ARTICLE

ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine- innervated brain regions. II. Immunocytochemical localization in rat brain

CC Ouimet, HC Hemmings Jr and P Greengard
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021.

ARPP-21, a cAMP-regulated phosphoprotein, has been studied by immunocytochemistry to determine its cellular and regional distribution in rat brain. This study demonstrates that ARPP-21 immunoreactivity is present throughout the cytoplasm of immunoreactive neurons and that most of the immunoreactivity is associated with the basal ganglia. Within the caudatoputamen (CP), nucleus accumbens, olfactory tubercle, bed nucleus of the stria terminalis, and portions of the amygdaloid complex, ARPP-21 is present in neuronal somata and dendrites. In brain regions known to receive projections from these nuclei, immunoreactivity is present in puncta (presumed axons and axon terminals). These regions include the globus pallidus, ventral pallidum, entopeduncular nucleus, lateral preoptic area, and substantia nigra. Within the basal ganglia, ARPP-21 immunoreactivity is most intense in the olfactory tubercle, nucleus accumbens, medial portion of the CP, and the ventral retrochiasmatic pocket of the CP. These same areas comprise the limbic striatum, and ARPP-21 is the first substance found to be specifically enriched therein. The possibility is discussed that ARPP-21 mediates effects of multiple first messengers, including dopamine and vasoactive intestinal polypeptide, that act through cAMP.

This article has been cited by other articles:

				S. V. Rakhilin, P. A. Olson, A. Nishi, N. N. Starkova, A. A. Fienberg, A. C. Nairn, D. J. Surmeier, and P. Greengard A Network of Control Mediated by Regulator of Calcium/Calmodulin-Dependent Signaling Science, October 22, 2004; 306(5696): 698 - 701. [Abstract] [Full Text] [PDF]

				S. Ivkovic and M. E. Ehrlich Expression of the Striatal DARPP-32/ARPP-21 Phenotype in GABAergic Neurons Requires Neurotrophins In Vivo and In Vitro J. Neurosci., July 1, 1999; 19(13): 5409 - 5419. [Abstract] [Full Text] [PDF]

				H. Kawasaki, G. M. Springett, S. Toki, J. J. Canales, P. Harlan, J. P. Blumenstiel, E. J. Chen, I. A. Bany, N. Mochizuki, A. Ashbacher, et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia PNAS, October 27, 1998; 95(22): 13278 - 13283. [Abstract] [Full Text] [PDF]

				L Magrassi, M. Ehrlich, G Butti, S Pezzotta, S Govoni, and E Cattaneo Basal ganglia precursors found in aggregates following embryonic transplantation adopt a striatal phenotype in heterotopic locations Development, January 8, 1998; 125(15): 2847 - 2855. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help